Ardeparin Subcutaneous and Dapagliflozin and Metformin Extended-Release Tablets
Determining the interaction of Ardeparin Subcutaneous and Dapagliflozin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: dapagliflozin / metformin
Brand name: Xigduo XR
Synonyms: Dapagliflozin and metformin, Dapagliflozin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Dapagliflozin and saxagliptin
- Ardeparin Subcutaneous-Dapagliflozin Propanediol
- Ardeparin Subcutaneous-Dapsone
- Ardeparin Subcutaneous-Dapsone (Systemic)
- Ardeparin Subcutaneous-Dapsone Gel
- Ardeparin Subcutaneous-Dapsone topical
- Dapagliflozin and Metformin Extended-Release Tablets-Aredia
- Dapagliflozin and Metformin Extended-Release Tablets-Arestin
- Dapagliflozin and Metformin Extended-Release Tablets-Arestin eent
- Dapagliflozin and Metformin Extended-Release Tablets-Arestin mucous membrane powder
- Dapagliflozin and Metformin Extended-Release Tablets-Arformoterol
- Dapagliflozin and Metformin Extended-Release Tablets-Arformoterol inhalation